NanoChicago empowers pharmaceutical companies with cutting-edge technologies to advance drug development and patient care:

Nanoparticles (such as gold and silver) and DNA origami enable targeted drug delivery, controlled release systems, and advanced diagnostic kits.

Quantum dots provide real-time monitoring of drug efficacy and distribution at the cellular level, ensuring more precise treatments.

Graphene-MXene composites enhance the sensitivity of pharmaceutical compound detection, enabling faster and more accurate assessments.

These innovative technologies help streamline R&D processes, reduce trial times, and ultimately contribute to improved patient outcomes, driving progress in the pharmaceutical sector.